Therefore antioxidant agents that modulate Nrf2 would be expected to restore antioxidant and detoxifying enzymes by upregulation of phase 2 genes, counteract CS toxicity and to prevent of CS-related lung injury. Here, NFE2L2 is linked to Cowden syndrome 1.